US Stock MarketDetailed Quotes
IMUX Immunic
- 1.180
- +0.080+7.27%
Close Nov 25 16:00 ET
- 1.210
- +0.030+2.54%
Post 19:27 ET
106.29MMarket Cap-959P/E (TTM)
1.295High1.140Low1.52MVolume1.150Open1.100Pre Close1.86MTurnover2.89%Turnover RatioLossP/E (Static)90.08MShares2.11052wk High2.58P/B62.20MFloat Cap0.97052wk Low--Dividend TTM52.71MShs Float28.990Historical High--Div YieldTTM14.09%Amplitude0.945Historical Low1.220Avg Price1Lot Size
Immunic Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -20.17%-20.8M | 14.74%-17.03M | -22.84%-23.97M | -8.73%-70.83M | 7.13%-14.03M | -27.33%-17.31M | -26.73%-19.98M | 5.65%-19.51M | 21.73%-65.14M | 36.22%-15.1M |
| Net income from continuing operations | -7.02%-24.37M | 10.91%-21.38M | -17.06%-29.58M | 22.25%-93.61M | 61.80%-21.57M | -7.28%-22.77M | -9.58%-24M | -21.45%-25.27M | -29.55%-120.41M | -166.58%-56.47M |
| Operating gains losses | 19.15%56K | -426.85%-487K | 895.35%5.14M | -89.01%523K | -135.00%-189K | -97.78%47K | -92.37%149K | 246.31%516K | 9.81%4.76M | -52.21%540K |
| Depreciation and amortization | 23.53%42K | 40.91%31K | -18.75%26K | 44.16%111K | 21.05%23K | 100.00%34K | 10.00%22K | 52.38%32K | -9.41%77K | -52.50%19K |
| Other non cash items | --0 | --0 | --1.69M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -57.79%1.56M | 42.31%2.92M | -223.36%-3.99M | 57.90%15.05M | 1.98%6.07M | 2.90%3.69M | -2.28%2.05M | 253.03%3.23M | 202.71%9.53M | 216.04%5.96M |
| -Change in prepaid assets | ---- | ---- | ---- | -48.51%3.86M | ---- | ---- | ---- | ---- | 158.54%7.49M | ---- |
| -Change in payables and accrued expense | 318.18%414K | 56.93%2.91M | -242.28%-4.35M | 413.37%11.09M | 1,016.33%6.08M | -94.00%99K | 862.55%1.85M | 1,370.19%3.06M | -35.51%2.16M | -36.03%545K |
| -Change in other current assets | -69.60%1.09M | -107.41%-14K | 216.26%389K | ---- | ---- | 85.69%3.57M | -92.14%189K | 105.43%123K | ---- | ---- |
| -Change in other current liabilities | 176.19%58K | 141.67%29K | -149.02%-25K | 177.42%96K | 154.55%12K | 75.00%21K | 119.67%12K | 196.23%51K | -172.94%-124K | -104.31%-22K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -20.17%-20.8M | 14.74%-17.03M | -22.84%-23.97M | -8.73%-70.83M | 7.13%-14.03M | -27.33%-17.31M | -26.73%-19.98M | 5.65%-19.51M | 21.73%-65.14M | 36.22%-15.1M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -13.64%-50K | -104.15%-180K | -100.58%-31K | 197.14%9.46M | 98.29%-165K | 39.73%-44K | 15,585.71%4.34M | 44,558.33%5.34M | -14,438.81%-9.74M | -50,573.68%-9.63M |
| Net PPE purchase and sale | -13.64%-50K | -757.14%-180K | 70.19%-31K | -198.21%-334K | -16,600.00%-165K | 39.73%-44K | 25.00%-21K | -766.67%-104K | -67.16%-112K | 105.26%1K |
| Net investment purchase and sale | --0 | --0 | --0 | 201.73%9.8M | --0 | --0 | --4.36M | --5.44M | ---9.63M | ---9.63M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -13.64%-50K | -104.15%-180K | -100.58%-31K | 197.14%9.46M | 98.29%-165K | 39.73%-44K | 15,585.71%4.34M | 44,558.33%5.34M | -14,438.81%-9.74M | -50,573.68%-9.63M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 145,907.84%74.46M | -98.92%1.03M | -98.92%604K | 282K | -99.05%96K | -99.83%51K | 123.52%95.76M | 6,725.94%56.04M |
| Net common stock issuance | --0 | --0 | --191K | -97.85%853K | --571K | --282K | --0 | --0 | -7.40%39.58M | --0 |
| Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --55.99M | ---- |
| Proceeds from stock option exercised by employees | --74.27M | --0 | --0 | -3.74%180K | -36.54%33K | --0 | -26.15%96K | 920.00%51K | 103.26%187K | -43.48%52K |
| Net other financing activities | ---- | --0 | --74.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | 145,907.84%74.46M | -98.92%1.03M | -98.92%604K | --282K | -99.05%96K | -99.83%51K | 123.52%95.76M | 6,725.94%56.04M |
| Net cash flow | ||||||||||
| Beginning cash position | 3.11%79.7M | 4.91%97.31M | -56.28%46.67M | 22.89%106.75M | -17.98%59.69M | -12.24%77.29M | -3.08%92.76M | 22.89%106.75M | -31.85%86.86M | -34.11%72.77M |
| Current changes in cash | -22.13%-20.85M | -10.72%-17.21M | 457.22%50.46M | -389.02%-60.33M | -143.40%-13.59M | -24.91%-17.07M | -171.99%-15.54M | -257.84%-14.13M | 151.60%20.88M | 236.85%31.31M |
| Effect of exchange rate changes | 142.56%226K | -623.38%-403K | 21.68%174K | 126.38%262K | -78.50%573K | 67.58%-531K | 104.02%77K | 238.83%143K | -663.85%-993K | 479.63%2.67M |
| End cash Position | -1.04%59.07M | 3.11%79.7M | 4.91%97.31M | -56.28%46.67M | -56.28%46.67M | -17.98%59.69M | -12.24%77.29M | -3.08%92.76M | 22.89%106.75M | 22.89%106.75M |
| Free cash flow | -20.15%-20.85M | 13.93%-17.21M | -22.34%-24M | -9.05%-71.16M | 6.03%-14.19M | -26.97%-17.36M | -26.64%-20M | 5.20%-19.62M | 21.66%-65.26M | 36.27%-15.1M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data